Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001493152-26-012663
Filing Date
2026-03-25
Accepted
2026-03-25 16:05:24
Documents
3
Period of Report
2026-03-25

Document Format Files

Seq Description Document Type Size
1 6-K form6-k.htm 6-K 20916
2 EX-99.1 ex99-1.htm EX-99.1 26489
3 GRAPHIC ex99-1_001.jpg GRAPHIC 6763
  Complete submission text file 0001493152-26-012663.txt   57883
Mailing Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003
Business Address 29 HARAKEVET ST TEL AVIV - YAFO L3 6618003 972 54-255-3956
Nasus Pharma Ltd (Filer) CIK: 0002029039 (see all company filings)

EIN.: 516022712 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-42796 | Film No.: 26792429
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)